North America Bioreactors Market Forecast to 2030 - Regional Analysis - by Scale (Lab-Scale Production, Pilot-Scale Production, and Full-Scale Production), Application (Microbial Application, Cell Culture Application, and Others), Technology (Fed-Batch Bioreactors and Perfusion Bioreactors), and End User (Biopharma Manufacturers, Research and Development Organizations, and Contract Manufacturing Organization)
The North America bioreactors market was valued at US$ 1,575.60 million in 2022 and is expected to reach US$ 2,669.00 million by 2030; it is estimated to grow at a CAGR of 6.8% from 2022 to 2030 .
Increasing Adoption of Single-Use Bioreactors Fuels North America Bioreactors Market
Various manufacturers are developing single-use bioreactors (SUBs) as they are robust and provide the high performance required for commercial manufacturing of biopharmaceuticals. Advantages such as film technologies, stirring mechanisms, bioreactor designs, and sensor systems have contributed toward increasing the adoption of disposable reactors from the lab to the production scale. The single-use bioreactors provide next-generation cell and gene therapies and continuous bioprocessing. The advancements in cell-culture processes have developed higher titers and cell densities, which have facilitated the adoption of SUBs.
Single-use bioreactors reduce the risks of contamination and decrease production turnaround times. In the last few years, the use of single-use bioreactors has increased in modern biopharmaceutical processes owing to their unique ability to enhance flexibility, reduce investment, and limit operational costs. Also, many companies have developed single-use bioreactors for producing a wide range of therapeutics. For instance, in March 2021, Thermo Fischer Scientific launched the 3,000 L and 5,000 L HyPerforma DynaDrive single-use bioreactors.
The reduction in validation time has been one of the essential benefits of single-use bioreactors. The rising adoption of single-use bioreactors for upstream bioprocessing is driving the market growth. For instance, Sartorius AG offers a wide range of single-use bioreactors. The company provides ambr 15 for a 10–15 mL micro bioreactor scale and Biostat STR for 50–2000L. The increasing acceptance of single-use bioreactors for the production of therapeutics is driving the market for bioreactors.
North America Bioreactors Market Overview
The US is the largest market for bioreactors—several market players in the US manufacture bioreactors for various applications in pharmaceutical and biotechnology companies. Launch of new bioreactors, geographical expansion, and partnerships by market players drive the growth of the market. In April 2023, BioMADE announced five new projects focused on addressing the research and adoption gaps in bioindustrial manufacturing in the US by advancing bioreactor technology. With a funding commitment of US$ 10.5 million, these projects would span engineering, hardware development, and scalability to address the barriers to accelerate a robust economy. These projects focus on innovation and will advance the design and development of bioreactors, supported by Schmidt Futures. In April 2023, Cytiva launched X-platform bioreactors to simplify upstream bioprocessing operations with single-use products. Initially, available sizes of bioreactors were 50 and 200L. However, the X-Platform bioreactors are equipped with Figurate automation solution software and can increase process efficiency through ergonomic improvements, production capacity, and simplified supply chain operations.
North America Bioreactors Market Revenue and Forecast to 2030 (US$ Million)
North America Bioreactors Market Segmentation
The North America bioreactors market is segmented based on scale, application, technology, end user, and country. Based on scale, the North America bioreactors market is segmented into lab-scale production, pilot-scale production, and full-scale production. The pilot-scale production segment held the largest market share in 2022.
In terms of application, the North America bioreactors market is segmented into microbial application, cell culture application, and others. The cell culture application segment held the largest market share in 2022.
By technology, the North America bioreactors market is bifurcated into fed-batch bioreactors and perfusion bioreactors. The fed-batch bioreactors segment held a larger market share in 2022.
Based on end user, the North America bioreactors market is categorized into biopharma manufacturers, research and development organizations, and contract manufacturing organization. The research and development organizations segment held the largest market share in 2022.
Based on country, the North America bioreactors market is segmented into the US, Canada, and Mexico. The US dominated the North America bioreactors market share in 2022.
PBS Biotech Inc, General Electric Co, Merck KGaA, Thermo Fisher Scientific Inc, Sartorius AG, Pall Corp, Solaris Biotechnology SRL, and Applikon Biotechnology BV are some of the leading players operating in the North America bioreactors market.
Increasing Adoption of Single-Use Bioreactors Fuels North America Bioreactors Market
Various manufacturers are developing single-use bioreactors (SUBs) as they are robust and provide the high performance required for commercial manufacturing of biopharmaceuticals. Advantages such as film technologies, stirring mechanisms, bioreactor designs, and sensor systems have contributed toward increasing the adoption of disposable reactors from the lab to the production scale. The single-use bioreactors provide next-generation cell and gene therapies and continuous bioprocessing. The advancements in cell-culture processes have developed higher titers and cell densities, which have facilitated the adoption of SUBs.
Single-use bioreactors reduce the risks of contamination and decrease production turnaround times. In the last few years, the use of single-use bioreactors has increased in modern biopharmaceutical processes owing to their unique ability to enhance flexibility, reduce investment, and limit operational costs. Also, many companies have developed single-use bioreactors for producing a wide range of therapeutics. For instance, in March 2021, Thermo Fischer Scientific launched the 3,000 L and 5,000 L HyPerforma DynaDrive single-use bioreactors.
The reduction in validation time has been one of the essential benefits of single-use bioreactors. The rising adoption of single-use bioreactors for upstream bioprocessing is driving the market growth. For instance, Sartorius AG offers a wide range of single-use bioreactors. The company provides ambr 15 for a 10–15 mL micro bioreactor scale and Biostat STR for 50–2000L. The increasing acceptance of single-use bioreactors for the production of therapeutics is driving the market for bioreactors.
North America Bioreactors Market Overview
The US is the largest market for bioreactors—several market players in the US manufacture bioreactors for various applications in pharmaceutical and biotechnology companies. Launch of new bioreactors, geographical expansion, and partnerships by market players drive the growth of the market. In April 2023, BioMADE announced five new projects focused on addressing the research and adoption gaps in bioindustrial manufacturing in the US by advancing bioreactor technology. With a funding commitment of US$ 10.5 million, these projects would span engineering, hardware development, and scalability to address the barriers to accelerate a robust economy. These projects focus on innovation and will advance the design and development of bioreactors, supported by Schmidt Futures. In April 2023, Cytiva launched X-platform bioreactors to simplify upstream bioprocessing operations with single-use products. Initially, available sizes of bioreactors were 50 and 200L. However, the X-Platform bioreactors are equipped with Figurate automation solution software and can increase process efficiency through ergonomic improvements, production capacity, and simplified supply chain operations.
North America Bioreactors Market Revenue and Forecast to 2030 (US$ Million)
North America Bioreactors Market Segmentation
The North America bioreactors market is segmented based on scale, application, technology, end user, and country. Based on scale, the North America bioreactors market is segmented into lab-scale production, pilot-scale production, and full-scale production. The pilot-scale production segment held the largest market share in 2022.
In terms of application, the North America bioreactors market is segmented into microbial application, cell culture application, and others. The cell culture application segment held the largest market share in 2022.
By technology, the North America bioreactors market is bifurcated into fed-batch bioreactors and perfusion bioreactors. The fed-batch bioreactors segment held a larger market share in 2022.
Based on end user, the North America bioreactors market is categorized into biopharma manufacturers, research and development organizations, and contract manufacturing organization. The research and development organizations segment held the largest market share in 2022.
Based on country, the North America bioreactors market is segmented into the US, Canada, and Mexico. The US dominated the North America bioreactors market share in 2022.
PBS Biotech Inc, General Electric Co, Merck KGaA, Thermo Fisher Scientific Inc, Sartorius AG, Pall Corp, Solaris Biotechnology SRL, and Applikon Biotechnology BV are some of the leading players operating in the North America bioreactors market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. NORTH AMERICA BIOREACTORS MARKET - KEY INDUSTRY DYNAMICS
4.1 Bioreactors Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Increasing Adoption of Single-Use Bioreactors
4.2.2 Rapid Growth of Pharmaceutical and Biotechnology Industry
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.4 Market Opportunities
4.4.1 Rising Demand for Personalized Medicine
4.5 Future Trends
4.5.1 Technological Advancements in Bioreactors
4.6 Impact of Drivers and Restraints:
5. BIOREACTORS MARKET - NORTH AMERICA MARKET ANALYSIS
5.1 Overview
5.2 Bioreactors Market Revenue (US$ Million), 2020 – 2030
6. NORTH AMERICA BIOREACTORS MARKET ANALYSIS - SCALE
6.1 Overview
6.2 Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
6.3 Lab-Scale Production
6.3.1 Overview
6.3.2 Lab-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Pilot-Scale Production
6.4.1 Overview
6.4.2 Pilot-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Full-Scale Productions
6.5.1 Overview
6.5.2 Full-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
7. NORTH AMERICA BIOREACTORS MARKET ANALYSIS - APPLICATION
7.1 Overview
7.2 Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Microbial Application
7.3.1 Overview
7.3.2 Microbial Application Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Cell Culture Application
7.4.1 Overview
7.4.2 Cell Culture Application Market, Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
8. NORTH AMERICA BIOREACTORS MARKET ANALYSIS - TECHNOLOGY
8.1 Overview
8.2 Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Fed-Batch Bioreactors
8.3.1 Overview
8.3.2 Fed-Batch Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Perfusion Bioreactors
8.4.1 Overview
8.4.2 Perfusion Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
9. NORTH AMERICA BIOREACTORS MARKET ANALYSIS - END USER
9.1 Overview
9.2 Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharma Manufacturers
9.3.1 Overview
9.3.2 Biopharma Manufacturers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Research and Development Organizations
9.4.1 Overview
9.4.2 Research and Development Organizations Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Manufacturing Organization
9.5.1 Overview
9.5.2 Contract Manufacturing Organization Market, Revenue and Forecast to 2030 (US$ Million)
10. NORTH AMERICA BIOREACTORS MARKET – BY COUNTRY ANALYSIS
10.1 North America: Bioreactors Market
10.1.1 North America Bioreactors Market Revenue and Forecasts and Analysis - By Country
10.1.1.1 United States
10.1.1.2 Overview
10.1.1.3 US: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 United States Bioreactors Market Breakdown by Scale
10.1.1.3.2 United States Bioreactors Market Breakdown by Application
10.1.1.3.3 United States Bioreactors Market Breakdown by Technology
10.1.1.3.4 United States Bioreactors Market Breakdown by End User
10.1.1.4 Canada
10.1.1.5 Overview
10.1.1.6 Canada: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Canada Bioreactors Market Breakdown by Scale
10.1.1.6.2 Canada Bioreactors Market Breakdown by Application
10.1.1.6.3 Canada Bioreactors Market Breakdown by Technology
10.1.1.6.4 Canada Bioreactors Market Breakdown by End User
10.1.1.7 Mexico
10.1.1.8 Overview
10.1.1.9 Mexico: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.9.1 Mexico Bioreactors Market Breakdown by Scale
10.1.1.9.2 Mexico Bioreactors Market Breakdown by Application
10.1.1.9.3 Mexico Bioreactors Market Breakdown by Technology
10.1.1.9.4 Mexico Bioreactors Market Breakdown by End User
11. BIOREACTORS MARKET-INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Bioreactors Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 PBS Biotech Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 General Electric Co
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck KGaA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Sartorius AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Pall Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Solaris Biotechnology SRL
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Applikon Biotechnology BV
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. NORTH AMERICA BIOREACTORS MARKET - KEY INDUSTRY DYNAMICS
4.1 Bioreactors Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Increasing Adoption of Single-Use Bioreactors
4.2.2 Rapid Growth of Pharmaceutical and Biotechnology Industry
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.4 Market Opportunities
4.4.1 Rising Demand for Personalized Medicine
4.5 Future Trends
4.5.1 Technological Advancements in Bioreactors
4.6 Impact of Drivers and Restraints:
5. BIOREACTORS MARKET - NORTH AMERICA MARKET ANALYSIS
5.1 Overview
5.2 Bioreactors Market Revenue (US$ Million), 2020 – 2030
6. NORTH AMERICA BIOREACTORS MARKET ANALYSIS - SCALE
6.1 Overview
6.2 Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
6.3 Lab-Scale Production
6.3.1 Overview
6.3.2 Lab-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Pilot-Scale Production
6.4.1 Overview
6.4.2 Pilot-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Full-Scale Productions
6.5.1 Overview
6.5.2 Full-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
7. NORTH AMERICA BIOREACTORS MARKET ANALYSIS - APPLICATION
7.1 Overview
7.2 Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Microbial Application
7.3.1 Overview
7.3.2 Microbial Application Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Cell Culture Application
7.4.1 Overview
7.4.2 Cell Culture Application Market, Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
8. NORTH AMERICA BIOREACTORS MARKET ANALYSIS - TECHNOLOGY
8.1 Overview
8.2 Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Fed-Batch Bioreactors
8.3.1 Overview
8.3.2 Fed-Batch Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Perfusion Bioreactors
8.4.1 Overview
8.4.2 Perfusion Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
9. NORTH AMERICA BIOREACTORS MARKET ANALYSIS - END USER
9.1 Overview
9.2 Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharma Manufacturers
9.3.1 Overview
9.3.2 Biopharma Manufacturers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Research and Development Organizations
9.4.1 Overview
9.4.2 Research and Development Organizations Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Manufacturing Organization
9.5.1 Overview
9.5.2 Contract Manufacturing Organization Market, Revenue and Forecast to 2030 (US$ Million)
10. NORTH AMERICA BIOREACTORS MARKET – BY COUNTRY ANALYSIS
10.1 North America: Bioreactors Market
10.1.1 North America Bioreactors Market Revenue and Forecasts and Analysis - By Country
10.1.1.1 United States
10.1.1.2 Overview
10.1.1.3 US: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 United States Bioreactors Market Breakdown by Scale
10.1.1.3.2 United States Bioreactors Market Breakdown by Application
10.1.1.3.3 United States Bioreactors Market Breakdown by Technology
10.1.1.3.4 United States Bioreactors Market Breakdown by End User
10.1.1.4 Canada
10.1.1.5 Overview
10.1.1.6 Canada: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Canada Bioreactors Market Breakdown by Scale
10.1.1.6.2 Canada Bioreactors Market Breakdown by Application
10.1.1.6.3 Canada Bioreactors Market Breakdown by Technology
10.1.1.6.4 Canada Bioreactors Market Breakdown by End User
10.1.1.7 Mexico
10.1.1.8 Overview
10.1.1.9 Mexico: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.9.1 Mexico Bioreactors Market Breakdown by Scale
10.1.1.9.2 Mexico Bioreactors Market Breakdown by Application
10.1.1.9.3 Mexico Bioreactors Market Breakdown by Technology
10.1.1.9.4 Mexico Bioreactors Market Breakdown by End User
11. BIOREACTORS MARKET-INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Bioreactors Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 PBS Biotech Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 General Electric Co
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck KGaA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Sartorius AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Pall Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Solaris Biotechnology SRL
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Applikon Biotechnology BV
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
